Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

GHK-Cu and TB-500 Interaction: Synergistic | Peptide Database

Can you take GHK-Cu with TB-500? Synergistic interaction (95% confidence). See pharmacological analysis, organ load, safety flags, and dosing guidance.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Compound Profiles

GHK-Cu

Copper Peptide | Skin Regeneration & Anti-Aging Compound

Penetrates skin layers, activates fibroblasts, stimulates collagen and elastin synthesis, promotes angiogenesis, and modulates inflammatory responses. The copper ion is essential for enzyme cofactor activity in tissue repair processes.

TB-500

Synthetic Fragment (17-23) of Thymosin Beta-4

Acts as principal actin-sequestering protein, regulating cell migration, promoting angiogenesis, reducing inflammation, and activating stem cell differentiation for comprehensive regenerative effects..

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take GHK-Cu with TB-500?

Yes, GHK-Cu and TB-500 can generally be taken together. Enhanced wound healing and tissue repair when combined.

Is GHK-Cu and TB-500 safe together?

Based on documented research, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between GHK-Cu and TB-500?

Enhanced wound healing and tissue repair when combined. This assessment has 95% confidence and is based on documented research data.

How should I time GHK-Cu and TB-500?

GHK-Cu has a half-life of 0.5-2 hours and TB-500 has a half-life of ~2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.

Connected topics

Follow this recovery question